Archive for the ‘Latisse’ Category
by Jeffrey Clark on October 12, 2012
Watch the latest video at video.foxbusiness.com
OraSure CEO Douglas Michels announces partnership with product spokesman Magic Johnson to raise awareness for OraQuick, a new rapid HIV home test kit available for $39.99 at your local drugstore.
And Magic has already started pitching the product, as seen on The Daily Show with Jon Stewart this week.
The Daily Show with Jon Stewart
Get More: Daily Show Full Episodes,Political Humor & Satire Blog,The Daily Show on Facebook
Cancel reply
Leave a Comment
Name
According to Xconomy, there is a fundamental shift ongoing in the life sciences landscape as the East Coast retakes the lead as the center of the life sciences universe.
Twenty years ago, the world revolved around New Jersey, home to the largest concentration of life sciences employees, mostly employed by Big Pharma giants like Merck, Pfizer, BMS, J&J, Novartis and others. Just before the millenium, California took over with its concentration of companies and an eye for growth. Now, Boston is becoming the world’s biggest hub and, according to Luke Timmerman, will hold that title for some time to come.
The San Francisco Bay area still leads in 6 of 7 criteria in an Ernst & Young report (Boston is first in one and second in the others), but those metrics omit private companies and Big Pharma investment. Home to ThermoFisher, Boston Scientific, Genzyme, Biogen Idec, Covidien and being the most popular home to new startups drives home the point.
Xconomy
Cancel reply
Leave a Comment
Name
Ernst & Young has released the 2012 issue of Pulse of the Industry, the 5th annual report on the state of the medical technology industry.
The report examines the granular issues around funding constraints, pricing pressures, comparative effectiveness research and other trends that
The life sciences industry made front page news today in the New York Times…for all the wrong reasons.
Since 2009, a half dozen of the leading manufacturers of sterile injectable drugs have been warned by FDA as to their breaches in good manufacturing principles. Of these six, four have slowed production or closed factories altogether, leading to nearly 1/3 of the industry’s production capacity being currently off line.
The result? A critical shortage of particular drugs, a recent outbreak of meningitis that killed 19 patients as a result of improperly manufactured products, and a worrisome public. Luitpolod Pharmaceuticals, APP Pharmaceuticals, Hospira, Sandoz (Novartis), Ben Venue (Boehringer Ingelheim) and Teva are all involved. And, the implications for these companies, FDA and the general public are significant, as reported in the New York Times.
New York Times
Cancel reply
Leave a Comment
Name
Stryker has appointed Kevin Lobo, president of the company’s orthopedics division, to serve as its new CEO. Stryker’s search for a new CEO began after the abrupt departure of Steve MacMillan, who was forced out partly because certain board members became bothered by his handling of a relationship with a former flight attendant for the company’s corporate jets while his wife pursued a divorce. MacMillan left the company in a surprising announcement in early February. In May, the Wall Street Journal did a lengthy article detailing the specifics of his departure.
Lobo replaces interim CEO Curt Hartman, who will remain as an adviser to allow for a smooth transition.
Reuters
Cancel reply
Leave a Comment
Name
by Jeffrey Clark on October 23, 2012
The quality and appearance of this video are comical. Reminds us of an SNL skit or a low budget cable access channel program. Almost like Wayne’s World for healthcare investors.
Still, the content is legitimate as these two ‘pundits’ from The Motley Fool discuss the strategy and forecasts for AbVie, Abbott Labs’ spinoff of its own pharmaceutical business. Abbott has a roller coaster week with both good news and bad hitting the wire. The result was a two day sell off of 12% or more than $15B in market value of its stock.
Can somebody lend these guys $20 so they can invest in a new set background from Ikea?
Cancel reply
Leave a Comment
Name
Congressmen Erik Paulsen (R-MN) and Anna Eshoo (D-CA) are asking the FDA to issue quarterly reports informing lawmakers on whether the agency is satisfying the goals specified in the recently approved agreement on medical device user fees.
According to Paulsen, the move is intended to ensure that the FDA is in compliance with the user fee deal.
MassDevice.com (Boston)
Cancel reply
Leave a Comment
Name
Quest Diagnostics reorganizes
Posted on: December 22, 2012
Quest Diagnostics has announced its intent to set up two separate business units and replace its current structure by January 1st.
The two separate units will be Diagnostic Solutions and Diagnostic Information Services. The strategy is designed to drive efficiency within the Quest organization and eliminate redundancy. The plan will eliminate 400-600 management roles to reduce complexity of operations by the end of 2013.
GenomeWeb Daily News
Cancel reply
Leave a Comment
Name
Medical device companies, lobbyists and Congressional representatives of leading medical device states are pulling out all the stops in their ongoing strategy to repeal the looming medical device tax before (or shortly after) it takes affect in January 2013. At this point, it is the US Senate which is serving as the firewall to any repeal effort. And, Congress will not take up the issue before a new session begins in January, regardless as to which presidential candidate is elected. A Romney administration is likely to take months is its whole strategy to dismantle Obamacare. Another term for Obama means a tough road to hoe for those expecting Congress to remove such provisions that pay for healthcare reform. Either way, medical device companies and those that represent them are getting desperate.
So now the strategy is to attach the measure to a larger bill, one that Congress will likely take to a vote in the coming months. MassDevice details all the possible outcomes based upon the election, swing votes and the legislation expected as we approach a new Congressional term and the impending fiscal cliff.
MassDevice
Cancel reply
Leave a Comment
Name
Hurricane Sandy is affecting the life sciences industry in a big way with company offices closing from Maryland all the way to Boston. Those most affected include Big Pharma campuses in New Jersey, New York, Delaware & Philadelphia, including BMS, Astrazeneca, Merck, Pfizer, Novartis, GSK and Johnson & Johnson. From Beaker users on site, those offices are sparsely inhabited, if not completely vacant, this afternoon. Those who are in the office appear to be wondering why?
Vertex, Pfizer and Acorda Therapeutics have all delayed their scheduled earnings releases to later in the week, according to the Wall Street Journal.
There have been a rash of tweets from those concerned about people’s safety:
Our thoughts are with those people in the path of #sandy. Please stay safe.
— Life Technologies (
Latisse Review and Coupons 